ArticleBMJ open2024
Gender-sensitive and intersectionality-informed health indicators for health reporting: a scoping review protocol.
Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGender is a well-established social determinant of health and health (in)equality. Gender-sensitive health indicators for health monitoring and health reporting can support gender mainstreaming in relevant policy areas and inform strategies to promote gender equality. They generally lack theoretical approaches to explain gender inequalities in health in the context of individual, social and structural circumstances. Gender-sensitive and intersectionality-informed health indicators provide a more accurate and nuanced picture of health outcomes and risks but are often lacking. The aim of this scoping review is to map the evidence on gender-sensitive and intersectionality-informed indicators for health reporting in order to support the development of an indicator set for German Federal Health Reporting. METHODS AND ANALYSIS: This scoping review follows Arksey and O'Malley's methodological framework and its extension by Levac ETHICS AND DISSEMINATION: No ethical approval is required for this study. Findings will be disseminated through peer-reviewed publication, conference presentations and meetings with relevant stakeholders in health monitoring and reporting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.